Quick Takeaways
- GLAZER CAPITAL, LLC filed SCHEDULE 13G for scPharmaceuticals Inc. Common stock, par value $0.0001 per share (SCPH).
- Disclosed ownership: 4.6%.
- Date of event: 02 Sep 2025.
GLAZER CAPITAL, LLC - 02 Sep 2025 SCHEDULE 13G Report for scPharmaceuticals Inc. Common stock, par value $0.0001 per share (SCPH)
- Filing Manager
- GLAZER CAPITAL, LLC
- Reporting Manager
- Glazer Capital, LLC
- Symbol
- SCPH
- Shares outstanding
- 53,336,638 shares
- Disclosed Ownership
- 2,474,820 shares
- Ownership
- 4.6%
- Form type
- SCHEDULE 13G
- Filing time
- 10 Sep 2025, 14:34:07 UTC
- Date of event
- 02 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"GLAZER CAPITAL, LLC disclosed 4.6% ownership in scPharmaceuticals Inc. Common stock, par value $0.0001 per share (SCPH) on 02 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 10 Sep 2025, 14:34.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Glazer Capital, LLC | 4.6% | 2,474,820 | 0 | 2,474,820 | Paul J. Glazer | Paul J. Glazer, Managing Member | |
| Paul J. Glazer | 4.6% | 2,474,820 | 0 | 2,474,820 | Paul J. Glazer | Paul J. Glazer |